All News #Library
Rare Diseases
Incyte’s Retifanlimab Phase 3 Data in SCAC Published in Lancet
12 Jun 2025 //
BUSINESSWIRE
Ironwood spies new frontier for $1B drug in exploratory trial
29 Mar 2024 //
FIERCE BIOTECH
Tapping into the rare disease market
11 Mar 2017 //
BIO PHARMA DIVE

Market Place
Sourcing Support